BCYC — BICYCLE THERAPEUTICS PLC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1761612 ·
Last close
$4.41
Market Cap
$222.15M
52W High
$5.41
52W Low
$3.92
ADV30
563,125
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 887,000 | — | -65,589,000 | -60,825,000 | 652,396,000 | 559,474,000 | 98,076,000 |
| Dec 2025 | 47,955,000 | — | -24,657,000 | -20,154,000 | 717,597,000 | 628,110,000 | 107,620,000 |
| Sep 2025 | 11,734,000 | — | -65,709,000 | -59,100,000 | 763,954,000 | 648,325,000 | 145,475,000 |
| Jun 2025 | 2,920,000 | — | -87,347,000 | -78,952,000 | 832,184,000 | 721,451,000 | 163,269,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-229,230,000
Investing CF
$-2,459,000
Financing CF
$-144,000
CapEx
$-2,459,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.15
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-960,576,000
Inventory
—
Receivables
$40,917,000
ST Investments
—
EBIT TTM
$-217,417,000
Pretax Income TTM
$-217,620,000
Interest Exp TTM
$203,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$63,496,000
EBITDA
$-232,226,000
Free Cash Flow
$-109,748,248
Enterprise Value
$-252,326,080
Total Cash
$559,473,984
Total Debt
$15,337,000
Shares Out
50,373,281
Trailing EPS
$-3.15
Book Value
$7.95
ROE
-33.8%
ROA
-19.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 72,586,000 | -247,718,000 | -218,960,000 | 717,597,000 | 107,620,000 | — | -249,675,000 |
| Dec 2024 | 35,275,000 | -209,153,000 | -169,031,000 | 956,868,000 | 163,808,000 | — | -164,724,000 |
| Dec 2023 | 26,976,000 | -189,946,000 | -180,664,000 | 595,344,000 | 224,412,000 | — | -60,628,000 |
| Dec 2022 | 14,463,000 | -116,653,000 | -112,717,000 | 410,609,000 | 139,826,000 | — | -86,111,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.13
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NERV | Minerva Neurosciences, Inc. | $219.90M | $4.72 | — |
| NBP | NovaBridge Biosciences | $219.73M | $1.90 | — |
| CAMP | Camp4 Therapeutics Corp | $224.84M | $4.33 | — |
| RNA | Atrium Therapeutics, Inc. | $213.14M | $12.46 | — |
| SLNCF | Silence Therapeutics plc | $212.56M | $1.50 | — |
News headlines (Yahoo Finance, 1h cache)
Tarsus Pharmaceuticals (TARS) Moves 7.5% Higher: Will This Strength Last?
2026-07-03 09:05 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
2026-06-30 15:11 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
2026-06-17 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Tuesday Trading
2026-06-16 15:08 · Yahoo
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
2026-05-22 15:06 · Yahoo
European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday Trading
2026-05-07 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for Week
2026-05-01 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
2026-04-30 15:06 · Yahoo
Morgan Stanley Updates Bicycle Therapeutics plc (BCYC) Outlook Amid Pipeline Refocus
2026-04-17 13:58 · Yahoo
European Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading
2026-04-16 15:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.